News & Insights
President Trump Issues Executive Order to Move Cannabis to Schedule III of the Controlled Substances Act
President Trump has issued an Executive Order directing the rescheduling of cannabis to Schedule III under the Controlled Substances Act—a significant development with potential implications for cannabis operators, healthcare stakeholders, and other regulated industries.
At Feldman Legal Advisors, we break down what this executive order does (and does not) do, the legal and regulatory context, and what stakeholders should be watching as the process moves forward.
Feldman Legal Advisors Welcomes Dr. Jessica Steinberg as UK Associate
New York, NY, August 2025: Feldman Legal Advisors is delighted to announce that our law clerk, Jessica Steinberg, Ph.D., is now officially licensed to practice law in England and Wales, and has elevated her position with the firm to Associate based in London. Dr. Steinberg will continue working on behalf of clients across our cannabis, psychedelics, and corporate transactional legal practice.
June 2025 Newsletter
As the summer unfolds, we’re taking a moment to reflect with gratitude and excitement on the progress we’ve made, both personally and professionally. The movement for psychedelics and cannabis law reform continues to gain momentum, and we’re honored to be part of it alongside so many inspiring clients, collaborators, and advocates.
Teaching Business Law Makes Me A Better Lawyer
In his Law360 Expert Analysis article, David Feldman shares how teaching business law has made him a more effective and well-rounded attorney. Drawing from his experience in the classroom, David reflects on how the process of breaking down complex legal concepts for students sharpens his communication, deepens his subject mastery, and enhances client service.
Ohio Court Declares Cannabis Sale Contract Illegal, Highlights Ongoing Legal Risks
In a significant decision for the cannabis industry, a federal magistrate judge in Ohio recently dismissed a breach of contract suit involving the $5 million sale of a cannabis business, citing the federal prohibition against marijuana as the primary reason for the ruling. Consistent with a handful of other federal court rulings that have refused to enforce cannabis-related contracts due to the conflict with federal law, this decision underscores the ongoing legal risks for businesses operating in the cannabis space.
Hey Boomer! Pass That Joint…Thoughts on Marketing to Older Cannabis Users
Some of David Feldman’s lighthearted thoughts on cannabis marketing for adults over the age of 50.
Courtney Barnes attends Texas Cannabis Policy Conference at Texas A&M
FLA Partner, Courtney Barnes, attended the Texas Cannabis Policy Conference at Texas A&M from September 12-14, 2024. She connected with thought leaders, advocates, and policymakers to discuss the evolving landscape of cannabis legislation in Texas.
July 2024 Update: The Colorado Department of Regulatory Agencies Concludes Facilitator Rulemaking for Implementation of the Natural Medicine Health Act
As Colorado continues to lead in progressive health legislation, the Department of Regulatory Agencies (DORA), in charge of regulating the education, licensing, and conduct of facilitators, is at the forefront of implementing the Natural Medicine Health Act. The process has involved rigorous rulemaking to ensure the safe and effective administration of natural medicine services, including regulations on licensing, training, and professional conduct.